	Management of Nipple Necrosis and Wound Complications in Patients Undergoing Unilateral Skin-Sparing Mastectomy and Implant-Based Reconstruction for Breast Cancer: A Retrospective, Single-Center Study. Medicina (Kaunas) Akyuz S, Morkavuk , Gülçelik MA. PMID: 41901656 [PubMed - indexed for MEDLINE]
	Prognostic Impact of Early Metabolic Response on Interim 18F-FDG PET/CT in HR+/HER2- Metastatic Breast Cancer Treated with CDK4/6 Inhibitors. Medicina (Kaunas) Aliyev V, Güren AK, Guliyev M, Birsin Z, Günalt, Fidan MC, Çerme E, Abbasov H, Cebeci S, I, Sar, , Sa, Alan Ö, Demirci NS. PMID: 41901569 [PubMed - indexed for MEDLINE]
	FOXA1 and RAB25 as Biomarkers of Breast Cancer Cell Response to CYP1A1-Activated Prodrugs: Insights from CEU-938. Pharmaceuticals (Basel) Bruxelles Q, Hamel-Côté G, Scott-Boyer MP, Ouellette V, C-Gaudreault R, Durocher F, Diorio C, Droit A, Fortin S. PMID: 41901204 [PubMed]
	Effect of Nutrition Education Focusing on Dietary Quality on Cancer-Related Fatigue in Breast Cancer Patients: A 12-Week Randomized Controlled Trial. Nutrients Miao X, He J, Cheng L, Cheng X, Wang Y, Lin X, Huang Z, Wang R, Xia S. PMID: 41901069 [PubMed - indexed for MEDLINE]
	Identification of Glycoprotein Biomarkers in Breast Cancer by MALDI. Life (Basel) Aebisher D, Dynarowicz K, Rudy I, Rogó, Bartusik-Aebisher D, Kawczyk-Krupka A. PMID: 41901016 [PubMed]
	A Novel Hybrid CNN-ViT-Based Bi-Directional Cross-Guidance Fusion-Driven Breast Cancer Detection Model. Life (Basel) Sait ARW, Alkhurayyif Y. PMID: 41900992 [PubMed]
	The 3D Collagen Network as a Determinant of Tumor Progression and Drug Delivery Efficiency in Breast Cancer. Pharmaceutics Hirata M, Gonçalves RP, da Silva METPC, Feitosa GC, Spilla CSG, Roque DD, Fernandes LHB, Catharin VMCS, Catharin VCS, Campos LMG, de Souza ALDM, Pereira ESBM, de Souza JDSS, de Souza MDSS, Novais PC, Ferreira JC, Rici REG, Pomini KT. PMID: 41900826 [PubMed]
	Impact of Pre-Diagnosed Depressive Symptoms on Treatment Choice, Delay in Initiating Treatment, and Mortality Among Women Aged â‰¥65 Years with Breast Cancer. Int J Environ Res Public Health Gbogbo D, Tawk R, Ali AA, Reyes-Ortiz CA, Kiros GE. PMID: 41899738 [PubMed - indexed for MEDLINE]
	Evaluating the Use and Feasibility of Indocyanine Green (ICG) as a Beacon of Precision in Sentinel Node Biopsy for Breast Cancer from an Oncoplastic Practice in India. Cancers (Basel) Koppiker CB, Mishra R, Jain V, Bhandari S, Athavale N, Jumle N, Deshmukh C, Varghese B, Dhar U, Vartak A, Daphale P, Busheri L, Lulla V, Joshi S. PMID: 41899642 [PubMed]
	Decisional Conflict About Contralateral Prophylactic Mastectomy in Patients with Breast Cancer with and Without Pathogenic Variants in BRCA Genes. Cancers (Basel) Sung JH, Katapodi MC, Park SY. PMID: 41899639 [PubMed]
	Efficacy and Safety of Dalpiciclib in HR-Positive Advanced Breast Cancer: A Two-Center Retrospective Study. Cancers (Basel) Li J, Zong Z, Zhu D, Xu X, Yan Y, Li J, Li F, Hao J. PMID: 41899626 [PubMed]
	Ultra-Hypofractionated Whole-Breast Irradiation With or Without Simultaneous Integrated Boost Using Helical Tomotherapy for Early-Stage Breast Cancer: A Real-World Dosimetric and Clinical Outcome Study. Cancers (Basel) Hou PY, Hsieh CH, Yeh HP, Chuang EY. PMID: 41899617 [PubMed]
	Comparative Evaluation of Sentinel Lymph Node Detection Rates in Breast Cancer Surgery: "ICG + Patent Blue" Versus "99mTc + Patent Blue", a 11-Year Single-Center Study. Cancers (Basel) Hfaiedh I, Fruscalzo A, Sudan JS, Feki A, Guani B. PMID: 41899561 [PubMed]
	Psychometric Properties of the Breast Cancer Awareness Measure (Breast-CAM): A Systematic Review and Meta-Analysis. Cancers (Basel) Fejer A, Atbaei MA, Zand A, Varjas T, Kiss Z. PMID: 41899558 [PubMed]
	Overcoming Trastuzumab-Pertuzumab Resistance and Optimizing Sequential Anti-HER2 Therapy in HER2-Positive Metastatic Breast Cancer. Cancers (Basel) Yamamoto Y. PMID: 41899536 [PubMed]
	The Interplay Between Circadian Clocks and the Tumour Microenvironment in Breast Cancer. Cancers (Basel) Finger AM, Ector C, Weaver VM. PMID: 41899529 [PubMed]
	Clinical Significance of Achieving No Evidence of Disease in HER2-Positive Metastatic Breast Cancer: A Multicenter Study by Turkish Oncology Group (TOG). Cancers (Basel) Dursun B, Yasl, Sekmek S, Önder T, Y, Acar Ö, Sever N, Gökçek S, Ön S, Aslan F, Keskin GS, , Sava, Kalender ME, Payda, Bal Ö, Arslan ÜY, , Çakar B, Türk HM, Akbulut H. PMID: 41899520 [PubMed]
	Immunotherapies for Breast Cancer: From Checkpoint Inhibition to Emerging Cellular Therapies. Cancers (Basel) Tsagkaraki I, Gannon I, Rampotas A, Singh D, Roddy H, Ottaviani D, Roddie C. PMID: 41899515 [PubMed]
	Circulating MicroRNA in Breast Cancer. Cancers (Basel) Sturzu A, Ma R, Xi Y. PMID: 41899505 [PubMed]
	Obesity and Tolerance to Neoadjuvant Chemotherapy in Breast Cancer: A Retrospective Cohort Study. Cancers (Basel) Machado MS, Santos MP, Relvas C, Pereira MQ, Sousa M, Santos E, Pereira BA, Parreira J, Esteves S, Ravasco P, Vaz F, Nunes H. PMID: 41899495 [PubMed]

Articles 1 - 20 / 216072

Page 1 of 10804



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy